With the Contingent Commitment Exchange, you can reach better agreements quicker and help more patients.
Set negotiation parameters in dimensions beyond just price and make a confidential set of "Contingent Commitments" to articulate what you'd be willing to do if the other parties agree.
Reach an agreement when the Exchange identifies a match. If there’s no match, a new round of negotiation starts.
When an agreement is reached, the deal becomes binding. The platform can then track the agreement and provide relevant insights.
Track and manage settled agreements, and leverage past experience to inform future agreements, negotiations and strategies.
Is willing to pay 150 gold coins for 1.5 years life extension.
Are willing to accept a different price in combo provided it doesn’t reduce their price as a monotherapy. Due to anti-trust regulations they cannot communicate with each other.
By making confidential contingent commitments on the CCX platform, Asterix Pharma and Betafix Pharma negotiate how to distribute their gold coins.
Asterix Pharma agrees to receive 80 gold coins, and Betafix agrees to receive 70 gold coins when their drugs are used in combo. CCX deal management allows the payer to automatically settle the agreement monthly without an increased administrative burden.
Is willing to have a different price provided there isn’t a big administrative burden.
Is willing to accept a lower price for elbow cancer provided the terms and prices for elbow and toenail cancer are separately negotiated.
By making confidential contingent commitments, Payer A and Asterfix Pharma agree on terms so patients of elbow cancer finally get their treatment.
Payer A reimburses Asterfix Pharma 60 gold coins for elbow cancer patients maintaining their 100 gold coin payment for toenail cancer. CCX deal management allows the payer to automatically settle the agreement monthly without an increased administrative burden.
Is willing to pay full price for whenever it actually cures a patient of old age.
Is willing to rebate the payer 100% for when the drug doesn’t work, provided they get paid when it does work.
Asterfix Pharma is able to upload its patient data into the CCX platform and Payer A receives a rebate whenever AwesomeDrug does not work. CCX deal management platform processes the data and communicates to Asterfix Pharma and Payer A quarterly on the rebates owed between them.
Is willing to do more deals if they had the time and resources to do so.
Payer A uploads their 20 existing deals to the CCX deal management platform to quickly and efficiently administer them, providing their team with the capacity to enter into the 20 additional Managed Entry Agreements that also go onto the CCX deal management platform.
Negotiate with the relevant parties revealing information to the platform, but not to the counterparts. The platform allows you to keep proprietary information and your negotiation position hidden unless a deal is reached. In cases where it applies it also helps with complex anti-trust regulations that limit communication.
Manage all existing and pending agreements in one place, and get notifications when it’s time to renegotiate.
Agreements satisfy the requirements and budgets of both pharma and payers—no preference is given to one involved party over another.
Increase patient access to complex therapies with more outcome- and value-based contracts, combination and indication-based therapies, even deals you never thought were possible.
Be upfront about what you want from an agreement before you actually start negotiations.
Remain compliant with Anti-Trust and Competition law which prohibits companies from discussing common price strategy.
Only share what you want, when you want. For example, set contingent commitments but remain private until a payer and/or other pharma company agrees to them.
Reduce the administrative burden associated with legacy negotiation and deal tracking processes—and get deals done in days, not months.